PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1574960
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1574960
Intra-Abdominal Infections Market, By Diagnosis, By Application, By Treatment, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
REPORT HIGHLIGHT
Intra-Abdominal Infections Market size was valued at USD 22,590.43 Million in 2023, expanding at a CAGR of 8.90% from 2024 to 2032.
The intra-abdominal infections market involves products and treatments for infections occurring inside the abdomen. These infections can affect organs like the stomach, intestines, and liver. They are often caused by bacteria and can lead to serious health issues if not treated promptly. The market includes antibiotics, surgical procedures, and medical devices used to manage these infections. With rising cases of obesity and other health conditions, the demand for effective treatments is growing. Overall, this market plays a crucial role in improving patient outcomes and healthcare quality.
Intra-Abdominal Infections Market- Market Dynamics
Rising antibiotic resistance fuels the demand for advanced treatment options.
Rising antibiotic resistance is increasing the demand for better treatments for intra-abdominal infections. As standard antibiotics become less effective, healthcare providers struggle to manage these infections. The Centres for Disease Control and Prevention (CDC) report that nearly 3 million antibiotic-resistant infections happen in the U.S. each year, highlighting the urgent need for new therapies. This issue not only affects patients' health but also puts a heavy strain on healthcare systems.
In response, researchers and pharmaceutical companies are working on new solutions, including novel antibiotics and alternative therapies. The goal is to develop these advanced treatments to improve patient outcomes and tackle infections that traditional methods can't manage anymore. This shift is crucial for ensuring better healthcare in the face of rising resistance.
Intra-Abdominal Infections Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.90% over the forecast period (2024-2032)
Based on Treatment segmentation, Beta-lactams was predicted to show maximum market share in the year 2023
Based on Application segmentation, Intra-Abdominal Abscesses was the leading type in 2023
Based on Diagnosis segmentation, Computed Tomography (CT) was the leading type in 2023
based on Region, North America was the leading revenue generator in 2023
Intra-Abdominal Infections Market- Segmentation Analysis:
The Global Intra-Abdominal Infections Market is segmented based on Diagnosis, Application, Treatment, and Region.
The market is divided into three categories based on Treatment: Chloramphenicol, Beta Lactams, Quinolones, and Aminoglycosides. In the Intra-Abdominal Infections market, Beta-lactams are the leading treatment option. They are popular because they effectively target a wide range of bacteria, including both gram-positive and gram-negative types commonly associated with these infections.
Beta-lactams, such as penicillin and cephalosporins, are often the first choice for treatment due to their effectiveness and good safety record. They can also penetrate tissues easily, making them effective against intra-abdominal germs. As more surgeries are performed, leading to a rise in infections, the demand for Beta-lactamases continues to grow, reinforcing their top position in this market segment.
The market is divided into five categories based on Application: Intra-abdominal Abscess, Appendicitis, Diverticulitis, diarrhea, Food Poisoning, Infection by Helicobacter Pylori, and Others. In the Intra-Abdominal Infections market, the most dominant segment is Intra-Abdominal Abscesses. These are common in clinical settings and often occur as complications from conditions like appendicitis and diverticulitis. Intra-abdominal abscesses can lead to issues, such as sepsis, which makes quick and effective treatment essential. The need for surgery and antibiotic therapy to treat these infections also boost the market.
Intra-Abdominal Infections Market- Geographical Insights
The largest region in the Intra-Abdominal Infections market is North America. This area has a high number of hospitals and advanced healthcare systems, which support the diagnosis and treatment of these infections. The rise in surgical procedures and the increasing prevalence of obesity are leading to more intra-abdominal infections.
There is also strong research and development in new treatments, driven by major healthcare companies. Patients have access to antibiotics and other therapies. The North American market is expected to grow due to increasing awareness of infection management and several contributing factors.
Intra-Abdominal Infections Market- Competitive Landscape:
The intra-abdominal infections market features several players focused on developing effective treatments for these conditions. Merck & Co. leads with a range of antibiotics and innovative therapies. Pfizer Inc. offers a variety of effective medications, while AstraZeneca is known for its research in this field.
AbbVie Inc. focuses on targeted therapies to combat infections, and Bayer AG provides a mix of treatments and supportive care. GSK (GlaxoSmithKline) is also committed to investing in new drug discoveries. As awareness of intra-abdominal infections grows, these companies compete to improve existing products and introduce new therapies, driving market growth.
Recent Developments:
In January 2024, The NPPA reduced prices of antibiotics from Cipla and Wockhardt following their off-patent status, aiming to enhance accessibility and affordability for patients.
In January 2023, BDR Pharmaceuticals launched a new generic antibiotic, Ceftazidime + Avibactam, designed to combat gram-negative infections. This combination aims to enhance treatment options for challenging bacterial pathogens, addressing growing concerns over antibiotic resistance.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL INTRA-ABDOMINAL INFECTIONS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Pfizer Inc.
- Merck & Co., Inc.
- AstraZeneca PLC
- Bayer AG
- Allergan (AbbVie)
- GlaxoSmithKline plc
- Eli Lilly and Company
- Sanofi S.A.
- F. Hoffmann-La Roche Ltd
- Johnson & Johnson
- Basilea Pharmaceutica Ltd
- Shionogi & Co., Ltd.
- Achaogen, Inc.
- Melinta Therapeutics, Inc.
- Tetraphase Pharmaceuticals, Inc.
- The Medicines Company
- Dr. Reddy's Laboratories Ltd
GLOBAL INTRA-ABDOMINAL INFECTIONS MARKET, BY DIAGNOSIS- MARKET ANALYSIS, 2019 - 2032
- Abdominal X-ray
- Blood Tests
- Computed Tomography (CT)
- Ultrasound
GLOBAL INTRA-ABDOMINAL INFECTIONS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
- Intra-abdominal Abscess
- Appendicitis
- Diverticulitis
- Diarrhea
- Food Poisoning
- Infection by Helicobacter Pylori
- Others
GLOBAL INTRA-ABDOMINAL INFECTIONS MARKET, BY TREATMENT- MARKET ANALYSIS, 2019 - 2032
- Chloramphenicol
- Beta Lactams
- Quinolones
- Aminoglycosides
- Others
GLOBAL INTRA-ABDOMINAL INFECTIONS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Table of Contents
1. Intra-Abdominal Infections Market Overview
- 1.1. Study Scope
- 1.2. Market Estimation Years
2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. Intra-Abdominal Infections Market Snippet by Diagnosis
- 2.1.2. Intra-Abdominal Infections Market Snippet by Application
- 2.1.3. Intra-Abdominal Infections Market Snippet by Treatment
- 2.1.4. Intra-Abdominal Infections Market Snippet by Country
- 2.1.5. Intra-Abdominal Infections Market Snippet by Region
- 2.2. Competitive Insights
3. Intra-Abdominal Infections Key Market Trends
- 3.1. Intra-Abdominal Infections Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. Intra-Abdominal Infections Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. Intra-Abdominal Infections Market Opportunities
- 3.4. Intra-Abdominal Infections Market Future Trends
4. Intra-Abdominal Infections Industry Study
- 4.1. PEST Analysis
- 4.2. Porter's Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
5. Intra-Abdominal Infections Market: COVID-19 Impact Analysis
- 5.1. Pre-COVID-19 Impact Analysis
- 5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments
6. Intra-Abdominal Infections Market Landscape
- 6.1. Intra-Abdominal Infections Market Share Analysis, 2023
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis
7. Intra-Abdominal Infections Market - By Diagnosis
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Diagnosis, 2023 & 2032 (%)
- 7.1.2. Abdominal X-ray
- 7.1.3. Blood Tests
- 7.1.4. Computed Tomography (CT)
- 7.1.5. Ultrasound
- 7.1.6. Others
8. Intra-Abdominal Infections Market - By Application
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
- 8.1.2. Intra-abdominal Abscess
- 8.1.3. Appendicitis
- 8.1.4. Diverticulitis
- 8.1.5. Diarrhoea
- 8.1.6. Food Poisoning
- 8.1.7. Infection by Helicobacter Pylori
- 8.1.8. Others
9. Intra-Abdominal Infections Market - By Treatment
- 9.1. Overview
- 9.1.1. Segment Share Analysis, By Treatment, 2023 & 2032 (%)
- 9.1.2. Chloramphenicol
- 9.1.3. Beta Lactams
- 9.1.4. Quinolones
- 9.1.5. Aminoglycosides
- 9.1.6. Others
10. Intra-Abdominal Infections Market- By Geography
- 10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
- 10.2. North America
- 10.2.1. Overview
- 10.2.2. Intra-Abdominal Infections Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.2.7. U.S.
- 10.2.7.1. Overview
- 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.2.7.3. U.S. Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.2.7.5. U.S. Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.2.8. Canada
- 10.2.8.1. Overview
- 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.2.8.3. Canada Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.2.8.5. Canada Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.3. Europe
- 10.3.1. Overview
- 10.3.2. Intra-Abdominal Infections Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.3.7. Germany
- 10.3.7.1. Overview
- 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.7.3. Germany Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.7.5. Germany Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.3.8. Italy
- 10.3.8.1. Overview
- 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.8.3. Italy Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.8.5. Italy Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.3.9. United Kingdom
- 10.3.9.1. Overview
- 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.9.3. United Kingdom Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.9.5. United Kingdom Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.3.10. France
- 10.3.10.1. Overview
- 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.10.3. France Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.10.5. France Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.3.11. Russia
- 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.11.2. Russia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.11.4. Russia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.3.12. Netherlands
- 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.12.2. Netherlands Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.12.4. Netherlands Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.3.13. Sweden
- 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.13.2. Sweden Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.13.4. Sweden Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.3.14. Poland
- 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.14.2. Poland Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.14.4. Poland Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.3.15. Rest of Europe
- 10.3.15.1. Overview
- 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.15.3. Rest of the Europe Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.15.5. Rest of the Europe Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Intra-Abdominal Infections Key Manufacturers in Asia Pacific
- 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.4.4. Asia Pacific Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.6. Asia Pacific Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.4.7. India
- 10.4.7.1. Overview
- 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.7.3. India Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.7.5. India Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.4.8. China
- 10.4.8.1. Overview
- 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.8.3. China Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.8.5. China Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.4.9. Japan
- 10.4.9.1. Overview
- 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.9.3. Japan Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.9.5. Japan Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.4.10. South Korea
- 10.4.10.1. Overview
- 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.10.3. South Korea Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.10.5. South Korea Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.4.11. Australia
- 10.4.11.1. Overview
- 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.11.3. Australia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.11.5. Australia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.4.12. Thailand
- 10.4.12.1. Overview
- 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.12.3. Thailand Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.12.5. Thailand Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.4.13. Indonesia
- 10.4.13.1. Overview
- 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.13.3. Indonesia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.13.5. Indonesia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.4.14. Philippines
- 10.4.14.1. Overview
- 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.14.3. Philippines Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.14.5. Philippines Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.4.15. Rest of APAC
- 10.4.15.1. Overview
- 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.15.3. Rest of APAC Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.15.5. Rest of APAC Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.5. Latin America
- 10.5.1. Overview
- 10.5.2. Intra-Abdominal Infections Key Manufacturers in Latin America
- 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.5.4. Latin America Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.6. Latin America Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.5.7. Brazil
- 10.5.7.1. Overview
- 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.5.7.3. Brazil Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.7.5. Brazil Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.5.8. Mexico
- 10.5.8.1. Overview
- 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.5.8.3. Mexico Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.8.5. Mexico Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.5.9. Argentina
- 10.5.9.1. Overview
- 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.5.9.3. Argentina Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.9.5. Argentina Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.5.10. Colombia
- 10.5.10.1. Overview
- 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.5.10.3. Colombia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.10.5. Colombia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.5.11. Rest of LATAM
- 10.5.11.1. Overview
- 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.5.11.3. Rest of LATAM Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.11.5. Rest of LATAM Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.6. Middle East and Africa
- 10.6.1. Overview
- 10.6.2. Intra-Abdominal Infections Key Manufacturers in Middle East and Africa
- 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.6.4. Middle East and Africa Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.6. Middle East and Africa Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.6.7. Saudi Arabia
- 10.6.7.1. Overview
- 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.7.3. Saudi Arabia Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.7.5. Saudi Arabia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.6.8. United Arab Emirates
- 10.6.8.1. Overview
- 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.8.3. United Arab Emirates Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.8.5. United Arab Emirates Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.6.9. Israel
- 10.6.9.1. Overview
- 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.9.3. Israel Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.9.5. Israel Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.6.10. Turkey
- 10.6.10.1. Overview
- 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.10.3. Turkey Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.10.5. Turkey Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.6.11. Algeria
- 10.6.11.1. Overview
- 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.11.3. Algeria Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.11.5. Algeria Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.6.12. Egypt
- 10.6.12.1. Overview
- 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.12.3. Egypt Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.12.5. Egypt Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 10.6.13. Rest of MEA
- 10.6.13.1. Overview
- 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.13.3. Rest of MEA Market Size and Forecast, By Diagnosis, 2019 - 2032 (US$ Million)
- 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.13.5. Rest of MEA Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
11. Key Vendor Analysis- Intra-Abdominal Infections Industry
- 11.1. Competitive Dashboard
- 11.2. Company Profiles
- 11.2.1. Pfizer Inc.
- 11.2.2. Merck & Co., Inc.
- 11.2.3. AstraZeneca PLC
- 11.2.4. Bayer AG
- 11.2.5. Allergan (AbbVie)
- 11.2.6. GlaxoSmithKline plc
- 11.2.7. Eli Lilly and Company
- 11.2.8. Sanofi S.A.
- 11.2.9. F. Hoffmann-La Roche Ltd
- 11.2.10. Johnson & Johnson
- 11.2.11. Basilea Pharmaceutica Ltd
- 11.2.12. Shionogi & Co., Ltd.
- 11.2.13. Achaogen, Inc.
- 11.2.14. Melinta Therapeutics, Inc.
- 11.2.15. Tetraphase Pharmaceuticals, Inc.
- 11.2.16. The Medicines Company
- 11.2.17. Dr. Reddy's Laboratories Ltd
12. 360 Degree Analyst View
13. Appendix
- 13.1. Research Methodology
- 13.2. References
- 13.3. Abbreviations
- 13.4. Disclaimer
- 13.5. Contact Us
